New novel Covid variant revealed with very limited cases in France Kumar Jeetendra | January 5, 2022 While it is true that the Omicron version of coronavirus continues to spread to people in large numbers around the globe, news of the emerging of a second extremely mutated version was widely reported on Tuesday, triggering the possibility of another round of infection. The variation, B.1.640, has been discovered predominantly in France at this …
Alembic Pharmaceuticals receives USFDA Final Approval for Entacapone Tablets USP, 200 mg. Kumar Jeetendra | January 6, 2022 6th January, 2022, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Entacapone Tablets USP, 200 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Comtan Tablets, 200 mg, of …
Dynamic Vapor Sorption (DVS): Examining the Interaction of water vapor with APIs and Pharmaceutical formulations investigation Kumar Jeetendra | January 6, 2022 The water vapor or absorbent properties of pharmaceutical products like excipients, packaging films and drug formulations are acknowledged as key aspects that determine their storage stability, processing, and performance. In accordance with the US Pharmacopeia, moisture is not considered to be an impurity. However, the presence of water in a drug must be monitored and …
Alembic Pharmaceuticals receives USFDA Tentative Approval for Vortioxetine Tablets 5 mg, 10 mg, 15 mg, and 20 mg. Kumar Jeetendra | January 7, 2022 7th January, 2022, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Vortioxetine Tablets 5 mg, 10 mg, 15 mg, and 20 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug …
Quick guide to inhaler testing and global pharmacopoeial requirements – Live Webinar in association with Copley Scientific & Apex inhalation Kumar Jeetendra | January 7, 2022 One of the enduring problems that this United States Pharmacopeia (USP) is the need to establish guidelines for testing standards that represent common use. Dry powder inhalers that are passive (DPIs) depend solely on the inhalation effort produced by the patient in order to generate an aerosol that can be breathed. In the past, DPIs have been …
This is Why Eppendorf High-Speed Centrifuges Helping in Speed Up Your Cell Harvesting Process! Kumar Jeetendra | January 7, 2022 A centrifuge is a device that uses centrifugal force to separate various components of a fluid. From academic institutions to large pharmaceutical companies, bioprocessing applications are common in the daily workflow of a wide range of laboratories. In downstream processes, the isolation, purification, and concentration of the product of interest from the live cell batch …
Alembic Pharmaceuticals receives USFDA Tentative Approval for Dronedarone Tablets USP, 400 mg. Kumar Jeetendra | January 10, 2022 10th January, 2022, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Dronedarone Tablets USP, 400 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Multaq Tablets, 400 mg, …
Indica Labs’ HALO AP® platform achieves CE-IVD certification for use in primary diagnosis Kumar Jeetendra | January 10, 2022 Albuquerque, NM, 10 January, 2022 – Life Science Newswire – Indica Labs, a leading provider of computational pathology software and services, is proud to announce that following ISO13485 certification, HALO AP® has received a CE Mark for use in primary diagnosis within the European Economic Area, Switzerland, and the UK. The HALO AP platform was …
Which digital communication mediums are most effective for Rx communications? Kumar Jeetendra | January 11, 2022 Online communication is an integral part of any pharmaceutical business’s doctor outreach efforts. Today, we have a whole array of mediums at our disposal – from traditional text messages, emails, and articles to modern-day infographics, podcasts, and webinars. Adding to this a whole lot of other elements such as the timing of the post, which …
Cipla to Present at the 40th Annual J.P. Morgan Healthcare Conference Kumar Jeetendra | January 12, 2022 India; January 12, 2022: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that it will participate at the 40th Annual J.P. Morgan Healthcare Conference, which is the largest healthcare investment symposium in the industry. Mr. Umang Vohra, MD and Global CEO, Cipla, will virtually present a corporate overview of the …
Biotium Introduces Unique Super-Sensitive RNA Prestain Loading Dye Kumar Jeetendra | January 12, 2022 Fremont, CA, January 5, 2022 – Life Science Newswire – Biotium, inventor of the popular GelRed® and GelGreen® DNA gel stains, announces the release of EMBER500™ RNA Prestain Loading Dye. This novel prestain loading dye is much more sensitive than conventional prestaining with ethidium bromide (EtBr). In addition, it is compatible with blue LED gel …
International Freezer Challenge 2022: Optimizing your cold storage practices! Kumar Jeetendra | January 17, 2022 Global warming is a challenge for mankind – Glasgow just reminded us again. Sustainability discussions primarily focus on energy consumption. There is no exception for laboratory devices. Even the most environmentally friendly and energy-efficient ultra-low temperature freezers still require a significant amount of energy to maintain extremely low temperatures of -80°C, 24 hours a day, …
